Share：
Share this content in WeChat
X
[Chinese][PDF]82387
• DWI Papers •
The diagnostic values of diffusion-weighted imaging for ovarian cancer
WANG Feng  LIU Jian-yu 

DOI:10.12015/issn.1674-8034.2016.08.003.


[Abstract] Ovarian cancer is the most lethal gynecological malignancy. Early diagnosis and accurate assessment of disease and treatment effect can benefit patients. In recent years, diffusion-weighted imaging(DWI) is applied more and more in ovarian cancer. This article aims to review the current research status and future development prospect of DWI in ovarian cancer.
[Keywords] Ovarian neoplasms；Magnetic resonance imaging；Diffusion weighted imaging

WANG Feng Department of Radiology, Peking University Third Hospital, Beijing 100191, China

LIU Jian-yu* Department of Radiology, Peking University Third Hospital, Beijing 100191, China

*Correspondence to: Liu JY, E-mail: jyliu5791@sina.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of Capital Characteristic Clinic Project No. Z131107002213049
Received  2016-06-15
Accepted  2016-07-23
DOI: 10.12015/issn.1674-8034.2016.08.003
DOI:10.12015/issn.1674-8034.2016.08.003.

[1]
DeSouza NM, Rockall A, Freeman S. Functional MR imaging in gynecologic cancer. Magn Reson Imaging Clin N Am, 2016, 24(1): 205-222.
[2]
Sala E, Rockall AG, Freeman SJ, et al. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology, 2013, 266(3): 717-740.
[3]
Dhanda S, Thakur M, Kerkar R, et al. Diffusion-weighted imaging of gynecologic tumors: diagnostic pearls and potential pitfalls. Radiographics, 2014, 34(5): 1393-1416.
[4]
Nougaret S, Tirumani SH, Addley H, et al. Pearls and pitfalls in MRI of gynecologic malignancy with diffusion-weighted technique. AJR Am J Roentgenol, 2013, 200(2): 261-276.
[5]
Sala E, Rockall A, Rangarajan D, et al. The role of dynamic contrastenhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol, 2010, 76(3): 367-385.
[6]
车树楠，崔晓琳，李静，等. MR扩散加权成像体素内不相干运动模型对于乳腺良恶性病变诊断价值的研究．磁共振成像, 2015, 6(7): 506-512.
[7]
Le BD, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology, 1988, 168(2): 497-505.
[8]
Bennett KM, Schmainda KM, Bennett RT, et al. Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med, 2003, 50(4): 727-734.
[9]
Malek M, Pourashraf M, Mousavi AS, et al. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI. Asian Pac J Cancer Prev, 2015, 16(8): 3407-3412.
[10]
郭永梅，黄云海，魏新华，等. 3.0 T动态增强磁共振对卵巢肿瘤的半定量及定量分析研究．磁共振成像, 2015, 6(10): 782-786.
[11]
Rockall AG. Diffusion weighted MRI in ovarian cancer. Curr Opin Oncol, 2014, 26(5): 529-535.
[12]
Fujii S, Kakite S, Nishihara K, et al. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging, 2008, 28(5): 1149-1156.
[13]
Zhang P, Cui Y, Li W, et al. Diagnostic accuracy of diffusion-weighted imaging with conventional MR imaging for differentiating complex solid and cystic ovarian tumors at 1.5 T. World J Surg Oncol, 2012, 10(1): 237.
[14]
Kierans AS, Bennett GL, Mussi TC, et al. Characterization of malignancy of adnexal lesions using ADC entropy: comparison with mean ADC and qualitative DWI assessment. J Magn Reson Imaging, 2013, 37(1): 164-171.
[15]
Mukuda N, Fujii S, Inoue C, et al. Apparent diffusion coefficient (ADC) measurement in ovarian tumor: Effect of region-of-interest methods on ADC values and diagnostic ability. J Magn Reson Imaging, 2016, 43(3): 720-725.
[16]
Morita S, Kojima S, Hirata M, et al. Perfusion fraction of diffusion-weighted MRI for predicting the presence of blood supply in ovarian masses. J Magn Reson Imaging, 2011, 34(5): 1131-1136.
[17]
Carter JS, Koopmeiners JS, Kuehn-Hajder JE, et al. Quantitative multiparametric MRI of ovarian cancer. J Magn Reson Imaging, 2013, 38(6): 1501-1509.
[18]
Thomassin-Naggara I, Darai E, Cuenod CA, et al. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol, 2009, 19(6): 1544-1552.
[19]
Thomassin-Naggara I, Aubert E, Rockall A, et al. Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology, 2013, 267(2): 432-443.
[20]
Tempany CM, Zou KH, Silverman SG, et al. Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiological Diagnostic Oncology Group. Radiology, 2000, 215(3): 761-767.
[21]
de Bree E, Koops W, Kroger R, et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol, 2004, 86(2): 64-73.
[22]
Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology, 2002, 223(2): 495-499.
[23]
Qayyum A, Coakley FV, Westphalen AC, et al. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol, 2005, 96(2): 301-306.
[24]
Low RN, Sebrechts CP, Barone RM, et al. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings-a feasibility study. AJR Am J Roentgenol, 2009, 193(2): 461-470.
[25]
Michielsen K, Vergote I, Beeck KOD, et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol, 2014, 24(4): 889-901.
[26]
Fujii S, Matsusue E, Kanasaki Y, et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol, 2008, 18(1): 18-23.
[27]
Espada M, Garcia-Flores JR, Jimenez M, et al. Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma. Eur Radiol, 2013, 23(9): 2636-2642.
[28]
Oh JW, Rha SE, Oh SN, et al. Diffusion-weighted MRI of epithelial ovarian cancers: correlation of apparent diffusion coefficient values with histologic grade and surgical stage. Eur J Radiol, 2015, 84(4): 590-595.
[29]
申彦，杨帆，刘劲松，等．卵巢浆液性癌的组织学分级与发病机制研究新进展．中华病理学杂志, 2011, 40(8): 507-510.
[30]
Kurman RJ, Shih I. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol, 2010, 34(3): 433-443.
[31]
Rustin GJ, Vergote I, Eisenhauer E, et al. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer, 2011, 21(2): 419-423.
[32]
Kyriazi S, Collins DJ, Messiou C, et al. Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients. Radiology, 2011, 261(1): 182-192.
[33]
Sala E, Priest AN, Kataoka M, et al. Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development. Eur Radiol, 2010, 20(2): 491-496.
[34]
Sala E, Kataoka MY, Priest AN, et al. Advanced ovarian cancer: multiparametric MR imaging demonstrates response and metastasis-specific effects. Radiology, 2012, 263(1): 149-159.
[35]
Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia, 2009, 11(2): 102-125.

PREV Correlation between estimated glomerular filtration rate(eGFR) and apparent diffusion coefficient (ADC) values of the kidneys
NEXT MRI of cerebral small vessel damage in sleep apnea syndrome(SAS)
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn